Neonatal hemochromatosis: failure of deferoxamine therapy.
We describe a premature neonate with severe hepatic dysfunction from birth which progressed to fatal hepatic failure at 3 months of age. The diagnosis of a familial disorder, neonatal hemochromatosis, was made, and therapy was attempted with deferoxamine. Features of iron metabolism are presented, and this infant's illness is contrasted with other liver diseases of infancy associated with hepatic iron overload.
Jonas
M M
MM
Department of Pediatrics, University of Miami School of Medicine, FL 33101.
Kaweblum
Y A
YA
Fojaco
R
R
D003676:Deferoxamine / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006432:Hemochromatosis / Q000150:complications* / Q000188:drug therapy / Q000235:genetics; D006801:Humans; D007231:Infant, Newborn; D007501:Iron / Q000378:metabolism*; D008099:Liver / Q000378:metabolism / Q000473:pathology; D008103:Liver Cirrhosis / Q000209:etiology / Q000378:metabolism / Q000473:pathology
D007501:Iron; D003676:Deferoxamine